Non Alcoholic Fatty Liver Disease Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
BFRG | F | Bullfrog AI Holdings, Inc | -4.97 | |
GLTO | F | Galecto, Inc. | 0.00 | |
SGMT | F | Sagimet Biosciences Inc. | 1.17 | |
AKRO | F | Akero Therapeutics, Inc. | -0.41 | |
ETNB | F | 89bio, Inc. | -2.29 | |
TERN | F | Terns Pharmaceuticals, Inc. | -0.52 | |
PLRX | F | Pliant Therapeutics, Inc. | 0.00 | |
IVA | F | Inventiva S.A. | 0.58 | |
GYRE | D | Gyre Therapeutics, Inc. | 0.00 | |
ALGS | D | Aligos Therapeutics, Inc. | -2.47 |
Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic Health Information Services
Related Stock Lists:
Steatohepatitis
Hepatitis
Alcohol
Medicine
Biopharmaceutical
Fibrosis
Idiopathic Pulmonary Fibrosis
Liver Disease
Pulmonary Fibrosis
Biology
Biotechnology
Breakthrough Therapy
Cancer
Chronic Liver Diseases
Clinical Medicine
Liver Fibrosis
Metabolic Disease
Obesity
Orphan Drug
Treatment Of Fibrosis
Related ETFs - A few ETFs which own one or more of the above listed Non Alcoholic Fatty Liver Disease stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
SURI | D | Simplify Exchange Traded Funds Simplify Propel Opportunities ETF | 4.85 | |
BBC | C | Virtus LifeSci Biotech Clinical Trials ETF | 2.61 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 1.76 | |
XBI | D | SPDR S&P Biotech ETF | 1.19 | |
BTEC | C | Principal Healthcare Innovators Index ETF | 0.78 |
Compare ETFs
Related Industries:
Biotechnology
Drug Manufacturers - Specialty & Generic
Health Information Services
Related Stock Lists:
Steatohepatitis
Hepatitis
Alcohol
Medicine
Biopharmaceutical
Fibrosis
Idiopathic Pulmonary Fibrosis
Liver Disease
Pulmonary Fibrosis
Biology
Biotechnology
Breakthrough Therapy
Cancer
Chronic Liver Diseases
Clinical Medicine
Liver Fibrosis
Metabolic Disease
Obesity
Orphan Drug
Treatment Of Fibrosis
- Non Alcoholic Fatty Liver Disease
Non-alcoholic fatty liver disease (NAFLD) is a condition in which fat builds up in the liver, causing inflammation and damage. It is the most common form of liver disease in the United States, affecting up to 25% of the population. NAFLD is closely linked to obesity, diabetes, and high cholesterol, and can lead to serious complications such as cirrhosis and liver cancer. Treatment typically involves lifestyle changes such as weight loss, exercise, and a healthy diet.
Popular Now
Recent Comments
- TraderMike on IZM
- SuccessfulGerbil321 on IZM
- TraderMike on IZM
- TraderMike on Today's Outage
- Crunching_The_Market on Today's Outage
From the Blog
Featured Articles